Hemcheck Sweden AB operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hemcheck Sweden AB with three other
pharmaceutical manufacturers in Europe:
Kancera AB
(2020
sales of 90,000.00 Swedish Kronor [US$10,430.10 ]
),
StenoCare A/S
(277,780.14 Swedish Kronor [US$32,191.94 ]
), and
Index Pharmaceuticals Holding Ab
(35,000.00 Swedish Kronor [US$4,056.15 ]
).
Sales Analysis.